INTRODUCTION

 
Cardiovascular Disease

Cardiovascular  
Disease

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide1. At Boehringer Ingelheim we address unmet medical need by providing innovative treatments that improve the care of patients suffering from a range of cardiovascular conditions including irregular heartbeat (atrial fibrillation), stroke, blood clots in deep veins or lungs (deep vein thrombosis or pulmonary embolism), high blood pressure (hypertension) or heart attack (myocardial infarction).

1 Vilahur G et al. Eur Heart J Suppl 2014; 16(Suppl_A): A7-A11.

Explore Our Products

Related content

NOAC safety in clinical practice: Evidence from the real world 06:52
01/06/2018
Author: Boehringer Ingelheim

NOAC safety in clinical practice: Evidence from the real world

NOAC safety in clinical practice: Evidence from the real world

NOACS What The Past 5 Years Taught Us 03:16
01/09/2019
Author: Boehringer Ingelheim

NOACS What The Past 5 Years Taught Us

NOACS What The Past 5 Years Taught Us


Production date: May 2019